Markets.com Logo
markets.com

AIMBU

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    --
  • Previous Close
    --
  • 52 Week Change
    --
  • Day Range
    --
  • 52 Week High/Low
    --
  • Dividend Per Share
    --
  • Market cap
    --
  • EPS
    --
  • Beta
    --
  • Volume
    --

About

AIMBU.US is a CUSIP for the AIM Ultra Short Bond ETF. It is an exchange-traded fund (ETF) that invests primarily in U.S. dollar-denominated investment-grade fixed-income securities with an average portfolio duration of one year or less. The fund seeks to provide current income while maintaining liquidity and preserving capital.
markets.com
GBP/USD Forecast: Can Sterling Hold 1.32 as Fed Rate-Hike Bets Rise?

GBP/USD Forecast: Can Sterling Hold 1.32 as Fed Rate-Hike Bets Rise?

Julian Parker|--
AUD to USD Forecast 2026–2030: Can the Aussie Reclaim 0.71 After the RBA’s Fourth Rate Hike?

AUD to USD Forecast 2026–2030: Can the Aussie Reclaim 0.71 After the RBA’s Fourth Rate Hike?

Julian Parker|--
USD/CAD Forecast 2026–2030: Can Fed–BoC Rate Divergence Push the Pair Above 1.42?

USD/CAD Forecast 2026–2030: Can Fed–BoC Rate Divergence Push the Pair Above 1.42?

Julian Parker|--
PCE+GDP: A Double Data Shock Could Move Markets

PCE+GDP: A Double Data Shock Could Move Markets

--
Micron vs SanDisk: Which Stock Is Better Positioned for AI Growth?

Micron vs SanDisk: Which Stock Is Better Positioned for AI Growth?

Julian Parker|--
AMD vs Intel vs Arm: Which Stock Could Benefit Most From the AI Inference Boom?

AMD vs Intel vs Arm: Which Stock Could Benefit Most From the AI Inference Boom?

Daniel Carter|--
AMD Joins the $1 Trillion Club as AI Demand Lifts Shares: AI Chip Stock Forecast and Outlook

AMD Joins the $1 Trillion Club as AI Demand Lifts Shares: AI Chip Stock Forecast and Outlook

Julian Parker|--

Factors

Company Performance: AIM ImmunoTech's success in clinical trials for its drug Ampligen directly impacts the stock price.

Market Sentiment: Overall investor confidence and risk appetite affect demand for biotech stocks like AIMBU.US.

Regulatory Approvals: FDA decisions on Ampligen's approval are major price catalysts.

Competition: Competing therapies in the same disease areas influence AIMBU.US value.

Financial Health: AIM ImmunoTech's cash reserves, debt levels, and burn rate affect investor perception.

Partnerships: Collaborations with other companies can positively impact AIMBU.US stock.

People Also Watch

Latest news

Micron Q4 Earnings Preview: AI Memory Demand Sets High Bar for MU Stock

Micron Q4 Earnings Preview: AI Memory Demand Sets High Bar for MU Stock

Julian Parker|--
Brent Eases as Gulf Exports Recover and US Offers Reserve Oil

Brent Eases as Gulf Exports Recover and US Offers Reserve Oil

Julian Parker|--
NFP Preview: US Jobs Report to Test Fed Rate-Hike Expectations

NFP Preview: US Jobs Report to Test Fed Rate-Hike Expectations

Julian Parker|--

Latest Education Articles

How to Trade NFP: Read the Jobs Report and Manage Risk

How to Trade NFP: Read the Jobs Report and Manage Risk

Julian Parker|--
Risk Management 101

Risk Management 101

Julian Parker|--
Best AI Stocks to Buy Now: 10 Best Performing AI Stocks to Watch in 2026

Best AI Stocks to Buy Now: 10 Best Performing AI Stocks to Watch in 2026

Julian Parker|--
Recommended Topics
markets.com